$20M sweet spot round size
Most of their 31 investments are in rounds between $8M and $30M
2016
Alpha-9 Theranostics Inc. raised $75M on December 14, 2022
Investors: Nextech Invest, Samsara BioCapital, Longitude Capital and Quark Venture
V-Wave raised $98M on December 16, 2021
Investors: Pontifax Venture Capital, Triventures, Pura Vida Investments, Aperture Venture Partners, BRM Group, ISF Israel Secondary Fund, Endeavour Vision and Quark Venture
Lyndra Therapeutics raised $61M on June 24, 2021
Investors: Gilead Sciences, ImpactAssets, The Invus Group, Polaris Partners, Limitless Ventures, Catalytic Impact Foundation and Quark Venture
Volastra Therapeutics raised $32M on April 6, 2021
Investors: Vida Ventures, LLC, ARCH Venture Partners, Catalio Capital Management, Polaris Partners and Quark Venture
Undisclosed raised $21M on March 11, 2021
Investors: Valence Life Sciences, Sanderling Ventures and Quark Venture
V-Wave raised $28M on September 22, 2020
Investors: Pura Vida Investments, Endeavour Vision, Triventures, BRM Group, Aperture Venture Partners, ISF Israel Secondary Fund, Pontifax Venture Capital and Quark Venture
EnClear Therapies raised $10M on February 19, 2020
Investors: Thiel Capital, Dolby Family Ventures, 20/20 HealthCare Partners, Bioverge, Presight Capital and Quark Venture
EYEVENSYS raised $30M on January 8, 2020
Investors: Pureos Bioventures, Pontifax Venture Capital, Karista and Quark Venture
Undisclosed raised $22M on December 18, 2019
Investors: DOCOR, Pontifax Venture Capital, Catalyst Investments and Quark Venture
Undisclosed raised $2M on December 3, 2019
Investors: Peregrine Ventures, Catalyst Investments and Quark Venture